Elke Gerlach

427 total citations
12 papers, 344 citations indexed

About

Elke Gerlach is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Elke Gerlach has authored 12 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Oncology. Recurrent topics in Elke Gerlach's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Peptidase Inhibition and Analysis (4 papers) and Cell death mechanisms and regulation (3 papers). Elke Gerlach is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Peptidase Inhibition and Analysis (4 papers) and Cell death mechanisms and regulation (3 papers). Elke Gerlach collaborates with scholars based in Germany, Ireland and Greece. Elke Gerlach's co-authors include Dieter Moosmayer, Klaus Pfizenmaier, Thomas Wüest, Harald Wajant, Peter Scheurich, Till Bartke, Nathalie Peters, Bodo Brocks, Jeannette Gerspach and Alexej Schmidt and has published in prestigious journals such as Oncogene, Journal of Chromatography A and European Journal of Biochemistry.

In The Last Decade

Elke Gerlach

12 papers receiving 340 citations

Peers

Elke Gerlach
Scott F. Winter United States
Giulia Chiaruttini United Kingdom
Siri Juell Norway
David W. Ohannesian United States
IFC McKenzie Australia
Josephine Salimu United Kingdom
Elke Gerlach
Citations per year, relative to Elke Gerlach Elke Gerlach (= 1×) peers Viktoria Schäfer

Countries citing papers authored by Elke Gerlach

Since Specialization
Citations

This map shows the geographic impact of Elke Gerlach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elke Gerlach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elke Gerlach more than expected).

Fields of papers citing papers by Elke Gerlach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elke Gerlach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elke Gerlach. The network helps show where Elke Gerlach may publish in the future.

Co-authorship network of co-authors of Elke Gerlach

This figure shows the co-authorship network connecting the top 25 collaborators of Elke Gerlach. A scholar is included among the top collaborators of Elke Gerlach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elke Gerlach. Elke Gerlach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Guttà, Cristiano, Elke Gerlach, Maria Feoktistova, et al.. (2019). TAK1 suppresses RIPK1-dependent cell death and is associated with disease progression in melanoma. Cell Death and Differentiation. 26(12). 2520–2534. 26 indexed citations
2.
Gerlach, Elke, et al.. (2012). Purification of a PEGylated single chain Fv. Journal of Chromatography A. 1236. 90–96. 7 indexed citations
3.
Wüest, Thomas, et al.. (2002). TNF-Selectokine: a novel prodrug generated for tumor targeting and site-specific activation of tumor necrosis factor. Oncogene. 21(27). 4257–4265. 28 indexed citations
4.
Wajant, Harald, Dieter Moosmayer, Thomas Wüest, et al.. (2001). Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative. Oncogene. 20(30). 4101–4106. 174 indexed citations
5.
Schmidt, Alexej, Dafne Müller, Thomas Wüest, et al.. (2001). Generation of human high‐affinity antibodies specific for the fibroblast activation protein by guided selection. European Journal of Biochemistry. 268(6). 1730–1738. 30 indexed citations
6.
Schmidt, Alexej, Dafne Müller, Elke Gerlach, et al.. (2001). Generation of human high-affinity antibodies specific for the fibroblast activation protein by guided selection. European Journal of Biochemistry. 268(6). 1730–1738. 4 indexed citations
8.
Vallon, Rüdiger, Ralph Müller, Dieter Moosmayer, Elke Gerlach, & Peter Angel. (1997). The Catalytic Domain of Activated Collagenase I (MMP‐1) is Absolutely Required for Interaction with Its Specific Inhibitor, Tissue Inhibitor of Metalloproteinases‐1 (TIMP‐1). European Journal of Biochemistry. 244(1). 81–88. 18 indexed citations
9.
Moosmayer, Dieter, Harald Wajant, Elke Gerlach, et al.. (1996). Characterization of Different Soluble TNF Receptor (TNFR80) Derivatives: Positive Influence of the Intracellular Domain on Receptor/Ligand Interaction and TNF Neutralization Capacity. Journal of Interferon & Cytokine Research. 16(6). 471–477. 17 indexed citations
10.
Moosmayer, Dieter, et al.. (1995). A Bivalent Immunoadhesin of the Human Interferon-γ Receptor Is an Effective Inhibitor of IFN-γ Activity. Journal of Interferon & Cytokine Research. 15(12). 1111–1115. 3 indexed citations
11.
Moosmayer, Dieter, et al.. (1994). Expression of complete human IFN-gamma receptor and its extracellular domain in insect cells: purification and characterization of the recombinant proteins.. PubMed. 13(2). 147–53. 4 indexed citations
12.
Moosmayer, Dieter, et al.. (1994). Coexpression of the human TNF receptors TR60 and TR80 in insect cells: analysis of receptor complex formation.. PubMed. 13(5). 295–301. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026